Stealth Peptides (US-Maryland) Drug Class: Small molecule Mechanism/Technology: Have an antioxidant that functions by blocking the activity of CD36, thereby providing mitochondrial protection via antioxidant scavenging action. It has very good BBB access and has provided significant reduction in infarct volume in animal studies. It is about to go into full toxicology in preparation for an IND within the next 9-12 months. Primary Indication: Cardiovascular and neurodegenerative indications Stage: Preclinical
